Behavioural abnormalities and retention rates of anti‐epilepsy drugs during long‐term treatment of epilepsy: a clinical perspective

Acta Neurologica Scandinavica

Volumn 92, Issue , 1995, Pages 7-10

  Schmidt, D ^a  

^a Epilepsy Research Group   (Germany)

Author keywords

behavioural abnormalities; intractable epilepsy; long term treatment; vigabatrin

Indexed keywords

4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; CARBAMAZEPINE; DRUG DERIVATIVE; OXCARBAZEPINE; VIGABATRIN;

CLINICAL TRIAL; COMPARATIVE STUDY; DOSE RESPONSE; EPILEPSY; HUMAN; PATIENT; PSYCHOLOGICAL ASPECT; PSYCHOSIS; REVIEW; SOCIAL BEHAVIOR; AMNESIA; ANTICONVULSANT THERAPY; CONFERENCE PAPER; MAJOR CLINICAL STUDY;

ANTICONVULSANTS; CARBAMAZEPINE; CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPILEPSY; GAMMA-AMINOBUTYRIC ACID; HUMANS; PATIENT DROPOUTS; PSYCHOSES, SUBSTANCE-INDUCED; SOCIAL BEHAVIOR; VIGABATRIN;

EID: 0029444707     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1995.tb00491.x     Document Type: Article

References (28)

1. Anticonvulsants
2. Behavioral effects of lamotrigine
3. Post‐ictal psychosis after right temporal lobectomy
4. Surgical versus medical treatment of epilepsy I. Outcome related to survival, seizures, and neurological deficit
5. Vi‐gabatrin and psychosis
6. Vigabatrin, psychosis, depression: a retrospective survey
7. Personal communication. Data on file
8. Vigabatrin (Sabril®) ‐ The strategy for preclinical and clinical evaluation
9. Vigabatrin: effect on brain GABA levels measured by nuclear magnetic resonance spectroscopy
10. Neuropsychiatry
11. The new anticonvulsant drugs: implications for avoidance of adverse effects
12. Vigabatrin as first add‐on treatment in carbamazepine‐resistant partial epilepsy patients
13. Efficacy and cost analysis comparison of vigab‐atrin therapy and epilepsy surgery in patients with intractable complex partial seizures
14. Randomised study in anti‐epilepsy drug withdrawal in patients in remission
15. Six‐year follow‐up study of the efficacy and safety of vigabatrin in patients with epilepsy
16. Survey of 260 epileptic patients treated with oxcarbazepine (Trileptal®) on a named‐patient basis
17. Comparison of carbamazepine, phenobarbital, phenytoin and primidone in partial and secondarily generalized tonic‐clonic seizures
18. A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy
19. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic‐clonic seizures in adults
20. γ‐vinyl GABA (vigabatrin): clinical experience in adult and adolescent patients with intractable epilepsy
21. A 7‐year follow‐up of vigabatrin‐treated patients with severe partial epilepsy
22. Evaluation of vigabatrin as an add‐on drug in the management of severe epilepsy
23. Vigabatrin in drug‐resistant partial epilepsy: a 5‐year follow‐up
24. A risk‐benefit assessment of vigabatrin in the treatment of neurological disorders
25. Development of tolerance to the anti‐convulsant effect of vigabatrin in amygdala‐kindled rats